Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer

SIMPLE SUMMARY: While molecular targeted therapy has marginally improved outcomes of patients with non-small cell lung cancer (NSCLC), NSCLC remains a significant health care challenge with a poor prognosis. We hypothesized that a broad-spectrum oncofetal chondroitin sulfate (CS) glycosaminoglycan m...

Descripción completa

Detalles Bibliográficos
Autores principales: Oo, Htoo Zarni, Lohinai, Zoltan, Khazamipour, Nastaran, Lo, Joey, Kumar, Gunjan, Pihl, Jessica, Adomat, Hans, Nabavi, Noushin, Behmanesh, Hakhamanesh, Zhai, Beibei, Dagil, Robert, Choudhary, Swati, Gustavsson, Tobias, Clausen, Thomas M., Esko, Jeffrey D., Allen, Jeffrey W., Thompson, Michael A., Tran, Nhan L., Moldvay, Judit, Dome, Balazs, Salanti, Ali, Al-Nakouzi, Nader, Weiss, Glen J., Daugaard, Mads
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430715/
https://www.ncbi.nlm.nih.gov/pubmed/34503301
http://dx.doi.org/10.3390/cancers13174489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430715/
https://www.ncbi.nlm.nih.gov/pubmed/34503301
http://dx.doi.org/10.3390/cancers13174489

Ejemplares similares